← Open Payments lookup

AJOKE KAZEEM: Open Payments

NPI 1588241558 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,697 in 37 payments from 12 companies in 2025. Trend: 2023 $1,893 · 2024 $1,886 · 2025 $2,697

Food & beverage: $2,697
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$426
E.R. Squibb & Sons, L.L.C.6$379
Otsuka America Pharmaceutical, Inc.4$288
Neurocrine BioSciences, Inc.4$281
Supernus Pharmaceuticals, Inc.4$273
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$272
Alkermes, Inc.2$211
Axsome Therapeutics, Inc.2$205
Vanda Pharmaceuticals Inc.4$159
Janssen Pharmaceuticals, Inc2$149

Products named: COBENFY, AUSTEDO XR, INGREZZA, Qelbree, CAPLYTA, LYBALVI, Auvelity, REXULTI.

Industry payments across TX — which companies pay providers there.